Bone mineral density in male thyroid carcinoma patients taking suppressive therapy with levothyroxine

被引：0
|
作者：
Jurasinovic, Z [1 ]
Pavlinovic, Z [1 ]
Medvedec, M [1 ]
Petrovic, R [1 ]
机构：
[1] Univ Zagreb, Univ Hosp, Clin Dept Nucl Med & Radiat Protect, Zagreb, Croatia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1999年 / 26卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PS13
引用
收藏
页码：1056 / 1056
页数：1
相关论文
共 50 条
  • [21] The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment
    Eftekhari, Mohammad
    Asadollahi, Abolfazl
    Beiki, Davood
    Izadyar, Sina
    Gholamrezanezhad, Ali
    Assadi, Majid
    Fard-Esfahani, Armaghan
    Fallahi, Babak
    Takavar, Abbas
    Saghari, Mohsen
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2008, 11 (03): : 160 - 163
  • [22] BONE-DENSITY AND THYROID-HORMONE SUPPRESSIVE THERAPY FOR THYROID-CARCINOMA
    EULRY, F
    BAUDUCEAU, B
    LECHEVALIER, D
    MAGNIN, J
    CROZES, P
    FLAGEAT, J
    GAUTIER, D
    REVUE DU RHUMATISME, 1992, 59 (04): : 247 - 252
  • [23] Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma
    Reverter, JL
    Holgado, S
    Alonso, N
    Salinas, I
    Granada, ML
    Sanmartí, A
    ENDOCRINE-RELATED CANCER, 2005, 12 (04) : 973 - 981
  • [24] LEVOTHYROXINE AS SUPPRESSIVE THERAPY FOR THYROID-NODULES
    GHARIB, H
    BIOMEDICINE & PHARMACOTHERAPY, 1988, 42 (03) : 221 - 221
  • [25] Levothyroxine suppressive therapy for solitary thyroid nodule
    Mainini, E
    Martinelli, I
    Morandi, G
    Villa, S
    Stefani, I
    Mazzi, C
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (10) : 796 - 799
  • [26] Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma
    Heijckmann, AC
    Huijberts, MSP
    Geusens, P
    de Vries, J
    Menheere, PPCA
    Wolffenbuttel, BHR
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (01) : 23 - 29
  • [27] Cognitive dysfunctions during chronic Thyrotropin-suppressive therapy with levothyroxine in patients with differentiated thyroid carcinoma
    Jaracz, J.
    Kucharska, A.
    Rajewska-Rager, A.
    Lacka, K.
    EUROPEAN PSYCHIATRY, 2008, 23 : S379 - S379
  • [28] Quality of Life, Muscle Strength, and Fatigue Perception in Patients on Suppressive Therapy With Levothyroxine for Differentiated Thyroid Carcinoma
    de Oliveira Chachamovitz, Dhianah Santini
    Vigario, Patricia dos Santos
    Nogueira Cordeiro, Monica Fabiola
    Natividade de Castro, Carmen Lucia
    Vaisman, Mario
    dos Santos Teixeira, Patricia de Fatima
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (04): : 354 - 361
  • [29] Effect of thyrotropin suppressive therapy on lumbar bone mineral density in patients with differentiated thyroid cancer: a retrospective cohort study
    Wang, Xinshui
    Teng, Ruoling
    Liu, Fenfen
    Liu, Ping
    Yang, Yujiao
    GLAND SURGERY, 2022, 11 (02) : 432 - 441
  • [30] Effects of levothyroxine therapy on bone mineral density and bone turnover markers in premenopausal women with thyroid cancer after thyroidectomy
    Duan Bin-Hong
    Du Fu-Man
    Liu Yu
    Wang Xu-Ping
    Bian Bing-Feng
    ENDOKRYNOLOGIA POLSKA, 2020, 71 (01) : 15 - 20
12345